CD93
CD93 (CD93 molecule, also known as C1qRP, CDw93, ECSM3, MXRA4 and C1QR1) is a cell-surface glycoprotein and type I membrane protein. It contributes to inflammation, phagocytosis, cell adhesion and endothelial cell function. Browse Assay Genie's current range of CD93 research reagents below, or read on for the biology behind the target.
CD93 is a cell surface receptor involved in inflammation, phagocytosis and cell adhesion. It enhances the uptake of apoptotic cells and immune complexes, acting as a receptor for defence collagens including surfactant protein A (SFTPA1), C1q and mannose-binding lectin (MBL2). In endothelial cells it activates angiogenesis: it associates with beta-dystroglycan, which leads to SRC-dependent phosphorylation and recruitment of CBL. CBL then provides a docking site for downstream signalling components such as CRKL, which enhances cell migration.
CD93 also acts as a receptor for the pan-endothelial extracellular matrix glycoprotein multimerin-2 (MMRN2) and for IGFBP7. Both ligands play non-redundant roles in CD93-mediated endothelial cell function. The protein is a key regulator of endothelial barrier function and acts by modulating VEGFR2 function. The intracellular cytoplasmic tail of CD93 interacts with moesin, a protein that links transmembrane proteins to the cytoskeleton and has a role in cytoskeletal remodelling.
The CD93 gene was originally identified as encoding a myeloid cell-specific marker. The protein was once thought to be the C1q receptor, hence the names C1qRP and C1QR1 and the UniProt name complement component C1q receptor. It is now thought to be involved mainly in intercellular adhesion and in the clearance of apoptotic cells. Earlier names include matrix-remodelling associated 4 and CD93 antigen. HGNC places it among the CD molecules, the C-type lectin domain containing group and the complement system regulators and receptors. Mouse and rat both have a Cd93 ortholog.
CD93 activates angiogenesis through beta-dystroglycan, SRC, CBL and CRKL signalling, and its ligands MMRN2 and IGFBP7 both contribute to endothelial cell function.
CD93 regulates endothelial barrier function by modulating VEGFR2 function, which makes it relevant to studies of vascular integrity and adhesion.
CD93 enhances the uptake of apoptotic cells and immune complexes, so it is studied in phagocytosis and in clearance mechanisms.
As a receptor for C1q, MBL2 and SFTPA1, CD93 links defence collagens to inflammation and cell adhesion.
CD93 is a cell surface receptor involved in inflammation, phagocytosis and cell adhesion. It enhances uptake of apoptotic cells and immune complexes, promotes angiogenesis through beta-dystroglycan and SRC signalling, and regulates endothelial barrier function by modulating VEGFR2 function.
The protein was first identified as a myeloid cell marker (CDw93) and was once thought to be the C1q receptor, giving C1qRP and C1QR1. Other aliases include ECSM3 and MXRA4, from the former name matrix-remodelling associated 4. Check the datasheet of any product for its validated reactivity.
Yes. Mouse and rat both have an ortholog named Cd93. The human protein is a type I membrane glycoprotein whose cytoplasmic tail interacts with moesin, a link to the cytoskeleton. Check the datasheet of any product for its validated reactivity.
Other CD molecules, myeloid and endothelial markers and adhesion proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NPY3; product specifications from Assay Genie datasheets.